Proteomics
has the potential to radically improve our understanding of disease
and wellness. Inproteo is working to develop novel instrumentation
and methodologies to unleash that potential to improve human health.
Successfully applying analytical chemistry to design,
create, and optimize novel instrumentation and methodologies
will generate actionable information for the discovery and development
of diagnostic and therapeutic agents.
Inproteo is uniquely positioned to combine the deep analytical chemistry
expertise of Indiana and Purdue Universities with the commercial and
therapeutic know-how of Eli Lilly. Our collaborative
and highly synergistic cross-institutional projects will
enable us to produce innovative technologies that can be licensed
or spun off into new companies. |
|
